$1.29
1.53% today
Nasdaq, Sep 16, 08:41 pm CET
ISIN
US1897631057
Symbol
CODX
Sector
Industry

Co-Diagnostics, Inc. Target price 2024 - Analyst rating & recommendation

Co-Diagnostics, Inc. Classifications & Recommendation:

Hold
100%

Co-Diagnostics, Inc. Price Target

Target Price $2.00
Price $1.31
Potential
Number of Estimates 1
1 Analyst has issued a Co-Diagnostics, Inc. price target 2025. The average Co-Diagnostics, Inc. target price is $2.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 0 Analysts recommend Co-Diagnostics, Inc. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Co-Diagnostics, Inc. stock has an average upside potential 2025 of . Most analysts recommend the Co-Diagnostics, Inc. stock at Hold.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 0.99 3.88
97.11% 291.41%
Net Margin -3,867.88% -543.50%
9,117.51% 85.95%

1 Analyst has issued a sales forecast Co-Diagnostics, Inc. 2024 . The average Co-Diagnostics, Inc. sales estimate is

$3.9m
Unlock
. This is
39.74% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.9m 39.74%
Unlock
, the lowest is
$3.9m 39.74%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $990k 97.11%
2024
$3.9m 291.41%
Unlock
2025
$1.5m 61.29%
Unlock

The average Co-Diagnostics, Inc. net profit estimate is

$-21.1m
Unlock
. This is
46.78% higher
Unlock
than the net profit for the last 12 months(TTM).

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-38.3m 166.67%
2024
$-21.1m 45.00%
Unlock
2025
$2.2m 110.59%
Unlock

Net Margin

2023 -3,867.88% 9,117.51%
2024
-543.50% 85.95%
Unlock
2025
148.91% 127.40%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share $ -1.20 -0.66
166.67% 45.00%
P/E negative
EV/Sales negative

The average Co-Diagnostics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.66
Unlock
. This is
46.77% higher
Unlock
than earnings per share in the financial year 2023.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-1.20 166.67%
2024
$-0.66 45.00%
Unlock
2025
$0.07 110.61%
Unlock

P/E ratio

Current -1.06 0.00%
2024
-1.98 86.79%
Unlock
2025
18.71 1,044.95%
Unlock

Based on analysts' sales estimates for 2024, the Co-Diagnostics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

-0.13
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
10.79
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -0.08 97.92%
2024
-0.13 61.25%
Unlock
2025
-0.33 158.37%
Unlock

P/S ratio

Current 6.50 25.31%
2024
10.79 65.93%
Unlock
2025
27.87 158.33%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today